Levels of apoptotic markers, including cleavage of caspase-7 and protein levels of PUMA, were increased in the aldometanib-treated HCC tissues (Fig. 3i), and pyroptosis was also increased, as evidenced by elevated levels of the cleaved form of GSDME (Fig. 3i). The gene discussed is GSDME; the disease is hepatocellular carcinoma.